Event Details

Science Shaping Our World-SHOW is an ongoing seminar and networking series that highlights cutting edge translational life science research and development. Our mission is to bring together a multidisciplinary audience spanning academia and industry providing exposure and insight into the life science advancements changing our world. March’s SHOW will focus on novel pathways within the life science space. Specifically, our panel speakers will highlight where and how they have applied their life science expertise and experience toward driving the life science innovation frontier.

Life Science Innovation Panelists:Kevin Bitterman, Ph.D., Principal/Polaris Venture PartnersDr. Bitterman joined Polaris Ventures in 2004 and focuses on investments in healthcare. Prior to joining Polaris Ventures, he completed his Ph.D. in genetics at Harvard Medical School. Dr. Bitterman is a cofounder of Genocea Biosciences and Sirtris Pharmaceuticals (GSK) and was the founding CEO at Visterra Inc. (formerly Parasol Therapeutics).

As the Director of the AIM lab Dr. Fischer is focused on medical robotics and using real time feedback to guide a surgical procedure. As co-founder of Surgisense he specializes in the design, development, testing, manufacturing, and marketing of next generation of “smart” sensing surgical instruments and medical devices to further enhance surgery, patient care, and patient safety.

Dr. Painter is currently studying the role of the adaptive immune response to melanoma in a zebra fish model. In her final year of graduate school, Dr. Painter was diagnosed with angiosarcoma (a rare and aggressive cancer), soon after she co-founded Angiosarcoma Awareness Inc., to generate interest and awareness within the biomedical research community for this orphan disease. Dr. Painter serves as the chief scientific officer of Angiosarcoma Awareness Inc., where she distributes funds to multiple labs engaged in collaborative efforts aimed at understanding angiosarcoma.

Kathleen Seyb, Ph.D., Associate Director, Target Biology/Ra PharmaceuticalsDr. Seyb has carried out research at the Harvard NeuroDiscovery Center, where she focused novel targets for diseases such as Alzheimer’s, Parkinson’s, and Amyotrophic Lateral Sclerosis. Currently, Dr. Seyb serves as the Associate Director of Target Biology at Ra Pharmaceuticals where the focus is the development of novel, peptide-like molecules as therapeutics for difficult to target protein-protein interactions.

Gordon Webster, Ph.D., Researcher in Synthetic Biology/Harvard Medical SchoolDr. Webster has worked in life science R&D in both Europe and the U.S., and initiated and managed the first translational oncology clinical trial at a multinational pharmaceutical company and has coached and led research project teams in large matrix organizations, as well as large, distributed teams of scientists and technical specialists, working together across multiple time zones.

Please join us for an amazing evening of science, innovation, and networking. Event registration $10.00 with event sign-in beginning at 5:30 PM. Presentation and discussion will follow from 6:00 – 8:00 PM. Further, you are encouraged to bring your business cards, and enthusiasm, for an evening of networking following the presentation from 8:00-9:00 PM. Light food and refreshments provided.

SHOW is also Coloci enabled so as to bring the future of networking to our members today. By becoming a SHOW-Coloci community member you will have the capability to discover people via interests (including suggestions on who to meet), view profiles, message other members (emails not disclosed), and connect with “interesting” members in-person at upcoming events (opt-in, location based, no tracking). We invite you to join us in becoming a member of our SHOW-Coloci community and lend your thoughts, insights, and perspectives to current and upcoming events while connecting with old friends, colleagues, and valuable new network contacts. See the link below to get started.

Please join us for an amazing evening of science, innovation, and networking. Event sign-in begins at 5:30 PM. Presentation and discussion will follow from 6:00 – 8:00 PM. Further, you are encouraged to bring your business cards, and enthusiasm, for an evening of networking following the presentation from 8:00-9:00 PM. Light food and refreshments provided.*

*Please note event subject to change

Harvard University, HC‐LITT, HCCL, and Harvard Catalyst do not endorse any company or product. The opinions expressed during this event are solely those of Munevar & Associates, Inc. and do not represent the views of Harvard Catalyst, HCLITT, HCCL, Harvard University and its affiliated academic health care centers, the National Center for Research Resources, or the National Institutes of Health.

Organizer

Munevar & Associates, Inc. is a life science technology development and commercialization solutions company. Our mission is to couple scientific and technological experience and expertise, with commercialization insight and perspective, toward the translation of novel life science centered innovations.

The company is comprised of an integrated, multidisciplinary team of scientists, engineers, and business professionals focused on supporting the advancement, development, and commercialization of cutting-edge products and services.

About the Harvard Catalyst Laboratory for Innovative Translational Technologies:

The Harvard Catalyst Laboratory for Innovative Translational Technologies (HC-LITT), originally created and located at the Harvard School of Dental Medicine, provides the Harvard research community (basic and clinical researchers) with early access to enabling leading-edge genomic and proteomic technologies.

An integral part of Harvard Catalyst, the HC-LITT accelerates the translation of laboratory research in therapeutics and diagnostics into the clinic. The laboratory's 'collaborative research model' is very distinct from the 'traditional core' centers.